Form 8-K - Current report:
SEC Accession No. 0000950170-25-088704
Filing Date
2025-06-23
Accepted
2025-06-23 07:02:41
Documents
27
Period of Report
2025-06-23
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lrmr-20250623.htm   iXBRL 8-K 48376
2 EX-99.1 lrmr-ex99_1.htm EX-99.1 40238
3 EX-99.2 lrmr-ex99_2.htm EX-99.2 20508
4 GRAPHIC img46574298_0.jpg GRAPHIC 282533
5 GRAPHIC lrmr-ex99_2s1.jpg GRAPHIC 195529
6 GRAPHIC lrmr-ex99_2s2.jpg GRAPHIC 696012
7 GRAPHIC lrmr-ex99_2s3.jpg GRAPHIC 309010
8 GRAPHIC lrmr-ex99_2s4.jpg GRAPHIC 507236
9 GRAPHIC lrmr-ex99_2s5.jpg GRAPHIC 423768
10 GRAPHIC lrmr-ex99_2s6.jpg GRAPHIC 339084
11 GRAPHIC lrmr-ex99_2s7.jpg GRAPHIC 371742
12 GRAPHIC lrmr-ex99_2s8.jpg GRAPHIC 319427
13 GRAPHIC lrmr-ex99_2s9.jpg GRAPHIC 399757
14 GRAPHIC lrmr-ex99_2s10.jpg GRAPHIC 352279
15 GRAPHIC lrmr-ex99_2s11.jpg GRAPHIC 314304
16 GRAPHIC lrmr-ex99_2s12.jpg GRAPHIC 368849
17 GRAPHIC lrmr-ex99_2s13.jpg GRAPHIC 427158
18 GRAPHIC lrmr-ex99_2s14.jpg GRAPHIC 334705
  Complete submission text file 0000950170-25-088704.txt   7973310

Data Files

Seq Description Document Type Size
19 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT lrmr-20250623.xsd EX-101.SCH 23893
29 EXTRACTED XBRL INSTANCE DOCUMENT lrmr-20250623_htm.xml XML 4533
Mailing Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004
Business Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004 844-511-9056
Larimar Therapeutics, Inc. (Filer) CIK: 0001374690 (see all company filings)

EIN.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36510 | Film No.: 251062946
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)